Picture of Aceragen logo

ACGN — Aceragen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: Idera Pharmaceuticals Inc Files Prospectus Supplement Related To Issuance And Sale Of Up To $35 Million Shares Of Common Stock

March 6 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS INC FILES PROSPECTUS SUPPLEMENT
RELATED TO
ISSUANCE AND SALE OF UP TO $35 MILLION OF SHARES OF COMMON STOCK
- SEC FILING

Source text: (https://bit.ly/2HnCvOV)
Further company coverage:  IDRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aceragen

See all news